ReleaseWire Connect

With the increasing prices of dental surgery appliances, Orthogen LLC has restructured the prices on their products to make it more affordable for dentists and other professionals. As a leader in their industry, the company has patented an innovative technology for effective bone regeneration, the NanoGen. Dental surgeons across the world have come to rely on the medical grade calcium sulfate products to deliver their patients a satisfying outcome.

Dental surgeries restore bone defects that develop in the mouth. Surgeons take advantage of patented bone regeneration products developed by companies like Orthogen, LLC. As one of the leading suppliers of bone graft material for dental procedures, Orthogen, LLC is proud to announce they have recently been named an authorized distributor of Integra Life Services, a major dental company that manufactures and supplies guided tissue regeneration membranes and wound dressing to dentists. With this authorization, surgeons and other dental customers can purchase all membranes and dressings they need for their procedures, in addition to bone graft materials from Orthogen, LLC.

Years of research and development have gone into producing two of the most trusted dental bone grafting materials for effective bone regeneration. Orthogen, LLC is one of the leading suppliers of patented products for bone regeneration surgeries. Their products are made from medical-grade calcium sulfate, and are safe to use in oral surgeries and post extraction procedures to regenerate bone in the extraction socket of the tooth. For the convenience of their customers, Orthogen, LLC is announcing new pricing models for their innovative DentoGen and NanoGen technologies.

When an individual loses tooth, an extraction socket is formed in the mouth. Typically sufficient bone is not available in the socket to place an implant. Bone grafts like NanoGen, offered by Orthogen, LLC, needs to be placed in the socket to encourage bone regeneration. A clinical study published in the journal Clinical Advances in Periodontics has revealed the effective use of NanoGen for guided bone regeneration in a molar extraction socket. Clinical Advances in Periodontics is an official journal of the American Academy of Periodontics.

After years of research and development, Orthogen LLC has been issued a patent for their commercialized and novel dental bone graft material, NanoGen. The product became the first nanotechnology-based dental bone graft allowed for marketing by the FDA. Over last 2 years, a clinical study was conducted to test the use of NanoGen in infrabony defects in patients with chronic periodontitis. Orthogen LLC is proud to announce that the study concluded, their development—NanoGen—was considered highly valuable in the treatment of periodontal defects.

There are many instances in which a bone grafting procedure is required. Bone grafting is commonly performed in dental area, sometimes to maintain the support for existing tooth and sometimes in order to build a bony area to place dental implants. Dental implants require the presence of robust bone structure in maxilla or mandible to ensure successful placement and effective performance in the long-term. Orthogen, LLC has developed and commercialized a novel nanotechnology-based bone graft, NanoGen, for such applications. Orthogen, LLC is pleased to announce a new patent has been issued for NanoGen technology. NanoGen is already recognized as the first nanotechnology-based bone graft approved by the FDA for clinical use.

Orthogen LLC, a leading developer of bone-grafting products for orthopedic and dental applications, is pleased to announce a promotion on its DentoGen and NanoGen products. When customers purchase 4 boxes of either DentoGen or NanoGen products, they will receive one box of same product for free. If they purchase ten boxes, they will receive three boxes of same product for free. With this promotion, savings can be as much as $429.00, the cost of NanoGen bone graft per case could be as low as $55.00.

Orthogen LLC, a leading provider of bone graft material for dental applications, is pleased to announce the appointment of Dr. Sachin Mamidwar as new CEO of the company. Previous CEO and Chairman of the Board of Orthogen LLC, Dr. Harold Alexander said, “The opinion of the owners was unanimously positive. It is with great pleasure that we therefore name Dr. Sachin Mamidwar the new CEO of the corporation. He has played a critical leadership role in the development and commercialization of our nanotechnology based bone graft material, NanoGen and in obtaining ISO certification for the company. I am sure he will continue to move the company forward providing unique and quality products to the dental and medical communities.” “I am excited to take this new responsibility”, said Dr. Sachin Mamidwar. “Since Orthogen, LLC’s formation in 2007, we have successfully pursued Small Business Innovation Research grant to develop the nanotechnology based bone graft material, NanoGen. This is the only nanotechnology-based material approved by US FDA for dental bone grafting purposes. Clinical studies have demonstrated outstanding results using NanoGen in extraction sockets, infrabony defects, class II furcation defects and sinus augmentation cases. It is now time to capitalize on these outstanding results to increase market penetration for this bone graft material. And I look forward to work on this challenge”, continued Dr. Mamidwar. He also said he would like to introduce Orthogen, LLC’s products in orthopedics and discussions about the same are ongoing with major orthopedic distributors in the US.

Orthogen LLC is pleased to announce that Sachin Mamidwar, General Manager of Orthogen, recently participated in OrthoTec 2013 panel discussing the future of orthopedics. Responsible for the development and marketing of dental bone grafting materials, Orthogen LLC has become a leader in the orthopedic and dental medical device industry. Other industry experts who participated in the panel included such opinionated experts as Susan Drapeau, director of biologics R&D at Medtronic, Michael Hiles, VP of research and clinical affairs at Cook BioTech, Arnold Caplan, professor of biology and director of the Skeletal research Center at Case Western Reserve University and Kevin Stone, orthopedic surgeon and founder of the Stone Clinic. Chief Medical and Science Officer, Stryker, Scott Bruder led the panel on the discussion on the development of tissue engineering.

Orthogen, LLC is pleased to announce new research on the efficiency of the NanoGen product. The new case study, “Effect of Nanocrystalline Calcium Sulfate Bone Graft Material in Bilateral Sinus Augmentation Procedure,” was conducted by Ziv Mazor DDS, a world-renowned periodontist. The case study was published in the Clinical Advances in Periodontics, the official publication of American Academy of Periodontics. The NanoGen bone graft product was used to perform bilateral sinus augmentation procedures. NanoGen is already highly recommended by dentists around the world, for the treatment of extraction sockets. The case provides information on the use of NanoGen in sinus augmentation cases and the concluding findings.